Ali Behbahani

Director at Nexo Therapeutics.

Raised on Nexo Therapeutics filings

$60M

of $60M offered across 1 Form D filing

Company

Biotech · Littleton, CO

Covalent drugs for cancer targets without binding pockets

Covalent drugs for cancer targets without binding pockets

Nexo Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Mar 27, 2026	Equity	$60M/ $60M	Form D/A

Also named on Nexo Therapeutics filings